Lumexa Imaging Holdings Inc (LMRI)

$8.05 -2.45 (-23.33%)
Market Cap 976.48M
Revenue (ttm) 1.02B
Net Income (ttm) -47.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 31.10
Profit Margin -4.60%
Debt to Equity Ratio 0.00
Volume 2,573,698
Avg Vol 938,486
Day's Range N/A - N/A
Shares Out 96.11M
Stochastic %K 87%
Beta N/A
Analysts Strong Sell
Price Target $19.29

Company Profile

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

Industry: Medical Devices
Sector: Healthcare
Phone: 919 763 1100
Address:
4200 Six Forks Road, Suite 1000, Raleigh, United States
Latest News on LMRI
Lumexa Imaging Holdings Earnings Call Transcript: Q1 2026

May 12, 2026, 5:00 PM EDT - 23 hours ago

Lumexa Imaging Holdings Earnings Call Transcript: Q1 2026

Lumexa Imaging Announces First Quarter 2026 Results

May 12, 2026, 4:07 PM EDT - 1 day ago

Lumexa Imaging Announces First Quarter 2026 Results

Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers

May 12, 2026, 4:05 PM EDT - 1 day ago

Lumexa Imaging Advances Growth Strategy by Adding Four New Imaging Centers

Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

Apr 28, 2026, 4:15 PM EDT - 15 days ago

Lumexa Imaging Announces First Quarter 2026 Earnings Conference Call Date

Lumexa Imaging appoints Lynch as Chief Growth Officer

2026-04-20T11:35:37.000Z - 23 days ago

Lumexa Imaging appoints Lynch as Chief Growth Officer

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Apr 20, 2026, 7:00 AM EDT - 23 days ago

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Lumexa Imaging price target lowered to $15 from $23 at Barclays

2026-04-14T09:45:30.000Z - 4 weeks ago

Lumexa Imaging price target lowered to $15 from $23 at Barclays

Lumexa Imaging price target lowered to $17 from $23 at Raymond James

2026-04-02T18:20:15.000Z - 5 weeks ago

Lumexa Imaging price target lowered to $17 from $23 at Raymond James

Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Mar 26, 2026, 6:55 PM EDT - 6 weeks ago

Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Lumexa Imaging Holdings Inc trading resumes

2026-03-26T13:40:35.000Z - 6 weeks ago

Lumexa Imaging Holdings Inc trading resumes

Lumexa Imaging Holdings Inc trading halted, volatility trading pause

2026-03-26T13:35:14.000Z - 6 weeks ago

Lumexa Imaging Holdings Inc trading halted, volatility trading pause

Lumexa Imaging Holdings Earnings Call Transcript: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 6 weeks ago

Lumexa Imaging Holdings Earnings Call Transcript: Q4 2025

Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance

Mar 26, 2026, 6:00 AM EDT - 6 weeks ago

Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance

Lumexa Imaging Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 10, 2026, 3:30 PM EDT - 2 months ago

Lumexa Imaging Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Lumexa Imaging Holdings Transcript: 47th Annual Raymond James Institutional Investor Conference

Mar 2, 2026, 3:25 PM EST - 2 months ago

Lumexa Imaging Holdings Transcript: 47th Annual Raymond James Institutional Investor Conference

Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results; Provides 2026 Financial Guidance and Earnings Conference Call Date

Mar 2, 2026, 6:00 AM EST - 2 months ago

Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results; Provides 2026 Financial Guidance and Earnings Conference Call Date

Lumexa Imaging Announces Participation in Upcoming Investor Conferences

Feb 17, 2026, 7:30 AM EST - 3 months ago

Lumexa Imaging Announces Participation in Upcoming Investor Conferences

Lumexa Imaging upgraded to Strong Buy from Outperform at Raymond James

2026-02-09T15:15:25.000Z - 3 months ago

Lumexa Imaging upgraded to Strong Buy from Outperform at Raymond James

RDNT

Lumexa Imaging jumps 8% to $11.68 after Raymond James upgrade

2026-02-09T15:15:16.000Z - 3 months ago

Lumexa Imaging jumps 8% to $11.68 after Raymond James upgrade

Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care

Jan 28, 2026, 7:00 AM EST - 3 months ago

Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care

Lumexa Imaging Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 4 months ago

Lumexa Imaging Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Lumexa Imaging Achieves Record De Novo Expansion in 2025

Jan 8, 2026, 7:00 AM EST - 4 months ago

Lumexa Imaging Achieves Record De Novo Expansion in 2025

Lumexa Imaging Announces Participation in Upcoming Investor Conference

Jan 5, 2026, 4:06 PM EST - 4 months ago

Lumexa Imaging Announces Participation in Upcoming Investor Conference

Lumexa Imaging initiated with an Overweight at Barclays

2026-01-05T12:55:17.000Z - 4 months ago

Lumexa Imaging initiated with an Overweight at Barclays

Lumexa Imaging initiated with a Buy at Deutsche Bank

2026-01-05T12:10:52.000Z - 4 months ago

Lumexa Imaging initiated with a Buy at Deutsche Bank

Lumexa Imaging initiated with an Outperform at Leerink

2026-01-05T11:41:27.000Z - 4 months ago

Lumexa Imaging initiated with an Outperform at Leerink

Lumexa Imaging initiated with an Outperform at Raymond James

2026-01-05T11:16:22.000Z - 4 months ago

Lumexa Imaging initiated with an Outperform at Raymond James

Lumexa Imaging initiated with an Outperform at William Blair

2026-01-05T11:16:06.000Z - 4 months ago

Lumexa Imaging initiated with an Outperform at William Blair

Lumexa Imaging initiated with an Overweight at Wells Fargo

2026-01-05T10:35:23.000Z - 4 months ago

Lumexa Imaging initiated with an Overweight at Wells Fargo

Lumexa Imaging initiated with a Buy at Jefferies

2026-01-05T09:55:11.000Z - 4 months ago

Lumexa Imaging initiated with a Buy at Jefferies

Lumexa Imaging valued at $1.76 billion as shares edge up in Nasdaq debut

Dec 11, 2025, 1:10 PM EST - 5 months ago

Lumexa Imaging valued at $1.76 billion as shares edge up in Nasdaq debut

Lumexa Imaging opens at $18.65, IPO priced at $18.50 per share

2025-12-11T18:05:11.000Z - 5 months ago

Lumexa Imaging opens at $18.65, IPO priced at $18.50 per share

Lumexa Imaging indicated to open at $19, IPO priced at $18.50

2025-12-11T15:25:19.000Z - 5 months ago

Lumexa Imaging indicated to open at $19, IPO priced at $18.50

Welsh Carson-backed Lumexa Imaging raises $463 million in US IPO

Dec 10, 2025, 6:26 PM EST - 5 months ago

Welsh Carson-backed Lumexa Imaging raises $463 million in US IPO

Lumexa Imaging Announces Pricing of Initial Public Offering

Dec 10, 2025, 6:01 PM EST - 5 months ago

Lumexa Imaging Announces Pricing of Initial Public Offering

Lumexa Imaging targets up to $1.89 billion valuation in US IPO

Dec 2, 2025, 6:54 AM EST - 5 months ago

Lumexa Imaging targets up to $1.89 billion valuation in US IPO

Lumexa Imaging IPO Registration Document (S-1)

Nov 17, 2025, 4:24 PM EST - 6 months ago

Lumexa Imaging IPO Registration Document (S-1)

Diagnostic imaging provider Lumexa Imaging Holdings files for an estimated $200 million IPO

Nov 17, 2025, 8:18 AM EST - 6 months ago

Diagnostic imaging provider Lumexa Imaging Holdings files for an estimated $200 million IPO